En Es
Categories

Eurofins Technologies

Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test kits and lab consumables in the fields of bioanalytical testing for the food, feed, environmental, biopharma, and clinical industries. The company offers a broad range of product test kits for Pathogens ...
Gold member
Products Covid-19Summary
Close

Covid-19 Eurofins Technologies

Clinical Laboratory

SARS-CoV-2 RT-PCR Assay
GSD NovaType II SARS-CoV-2

The GSD NovaType II SARS-CoV-2 Real-Time RT-PCR assay allows for the identification of relevant mutations associated with SARS-CoV-2 variants: B.1.1.7 (UK), B.1.351 (South Africa), and B.1.1.28 (P.1) (Brazil). The assay is intended as a confirmatory test for potential mutants and should only be performed after first testing patient specimens for the presence of SARS-CoV-2 RNA with a CE-IVD marked screening assay such as the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR kit.
More details

SARS-CoV-2 Ag Rapid Test (Nasal Swab)
GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab)

The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasopharyngeal swab specimen. The CE-IVD labeled rapid test detects SARS-CoV-2 antigens in 15 minutes with a diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%.
More details

SARS-CoV-2 IgG ELISA Kit
NovaLisa SARS-CoV-2 IgG

The NovaLisa SARS-CoV-2 IgG ELISA kit is intended for the qualitative detection of antibodies to the SARS-CoV-2 virus in human serum and plasma for diagnostics of exposure to coronavirus (COVID-19). The CE-IVD marked assay demonstrates high sensitivity with antibodies detected in all tested samples from patients PCR positive for SARS-CoV-2 12 days after symptom onset (100% sensitivity in this patient group), and a specificity of >98%.
More details

SARS-CoV-2 (COVID-19) Test
GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR

The GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR is intended for the qualitative determination of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) genomic RNA extracted from human respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab and bronchoalveolar lavage) specimen types. The assay simultaneously detects two target sequences inside the N gene while the multiplex PCR allows a streamlined workflow in one reaction and provides results in approximately two hours.
More details

SARS-CoV-2 (COVID-19) Antibody Test
INgezim COVID 19 DR

The INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. The dual recognition enzyme-linked immunosorbent assay (ELISA) capable of detecting semi-quantitatively total SARS-CoV-2 virus N-protein-specific antibodies (IgG, IgM and IgA) in a single human serum or plasma sample.
More details

SARS-CoV-2 (COVID-19) Antibody Test
INgezim COVID 19 CROM

The INgezim COVID 19 CROM is a dual recognition immunochromatographic assay capable of detecting specific COVID-19 (SARS-CoV-2) antibodies (IgG, IgA, and IgM) in serum and blood samples. The test is able to detect antibodies specific to SARS-CoV-2 in 94.5% of cases from day 19. There is no cross-reactivity with antibodies specific to other coronaviruses or agents related to human respiratory illnesses.
More details
Close

About Eurofins Technologies

Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test kits and lab consumables in the fields of bioanalytical testing for the food, feed, environmental, biopharma, and clinical industries. The company offers a broad range of product test kits for Pathogens, Allergens, GMOs, Mycotoxins, Veterinary Drugs Residues, Animal Species and Water testing.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 (COVID-19) Antibody Test

SARS-CoV-2 (COVID-19) Antibody Test

Model: INgezim COVID 19 DR
Request Information

Description:

The INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. The dual recognition enzyme-linked immunosorbent assay (ELISA) capable of detecting semi-quantitatively total SARS-CoV-2 virus N-protein-specific antibodies (IgG, IgM and IgA) in a single human serum or plasma sample.

Features

Features

• Total incubation time: 1 hour and 15 minutes

• Analytical sensitivity: 100% from day 17 after symptoms onset (85% between days 7 and 16)

• The specificity of the assay is 99,2%. There is no cross-reactivity with other respiratory coronaviruses (229E, NL63, OC43 and HKU1) and no interferences have been found for antibodies for respiratory viruses such as Influenza or RSV

• No sample pre-dilution required

• Compatible with various open platform ELISA analyzers

• CE-IVD marked Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Eurofins Technologies (SARS-CoV-2 (COVID-19) Antibody Test)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions